ULTI — Ultimovacs ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK285.91m
- NOK20.07m
Annual cashflow statement for Ultimovacs ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Depreciation | |||||
| Non-Cash Items | -63.2 | -117 | -152 | -163 | -201 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.86 | 6.39 | 23.9 | -6.99 | 8.88 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -63 | -108 | -126 | -168 | -190 |
| Capital Expenditures | -0.172 | -5.28 | -0.085 | -0.195 | -0.025 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4.49 | 4.55 | 3.06 | 8.89 | 14.1 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.32 | -0.736 | 2.98 | 8.69 | 14 |
| Financing Cash Flow Items | -25.7 | -7.3 | -11.2 | -0.105 | -0.38 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 343 | 151 | 260 | 3.58 | -1.85 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 284 | 41.3 | 133 | -149 | -159 |